Heart Lung Machine Market Size & Outlook, 2026-2034

Heart Lung Machine Market Overview

The global heart-lung machine market size is valued at USD 2.51 billion in 2025 and is estimated to reach USD 4.54 billion by 2034, growing at a CAGR of 6.86% during the forecast period. The observed market growth is stimulated by increasing adoption of hybrid operating rooms integrating real-time perfusion analytics for precise intraoperative control and improved surgical outcomes.

Key Market Trends & Insights

• North America held a dominant share of the global market, accounting for 41.29% in 2025.
• The Asia Pacific region is expected to grow at the fastest pace, with a CAGR of 8.47% during the forecast period.
• Based on the component, the monitoring systems segment is expected to register the fastest CAGR of 7.30% during 2026-2034.
• By application, the coronary artery bypass grafting segment dominated the market with a revenue share of 30.65% in 2025.
• By end use, the hospitals segment accounts for the highest revenue share of 79.86% in 2025.
• The U.S. dominates the heart-lung machine market, valued at USD 878.36 million in 2024 and reaching USD 934.84 million in 2025.

Table: U.S. Heart lung machine Market Size (USD Million)

Source: Straits Research

Market Size & Forecast

• 2025 Market Size: USD 2.51 billion
• 2034 Projected Market Size: USD 4.54 billion
• CAGR (2026-2034): 6.86%
• Dominating Region: North America
• Fastest-Growing Region: Asia Pacific

The heart-lung machine market comprises key components such as oxygenators, pumps, cannula, monitoring systems, heat exchangers, blood reservoirs, and supporting accessories. Heart-lung machines are widely used in applications including coronary artery bypass grafting, heart and lung transplants, and heart valve surgeries. Based on end use, these systems are primarily utilized in hospitals and specialized cardiac centers, supporting safe and controlled extracorporeal circulation during critical cardiac interventions.

Latest Market Trends

Integration of AI-enhanced perfusion monitoring systems

A major trend in the heart-lung machine market is the rapid adoption of AI-enhanced perfusion monitoring, where next-generation systems incorporate artificial intelligence algorithms to provide real-time data analytics, predictive flow control, and automated safety adjustments during cardiopulmonary bypass procedures. This technology improves surgical precision, reduces intraoperative complications, and supports optimized perfusion management, making it increasingly preferred by advanced cardiac centers worldwide.

Surge in the use of portable and emergency-ready heart-lung machines

A notable trend in the market is the increasing development and adoption of portable and emergency-ready cardiopulmonary bypass systems, driven by Medtronic’s launch of a mobile bypass unit designed for rapid deployment in remote or resource-limited settings. These compact systems support urgent cardiac interventions outside traditional operating rooms, enhancing accessibility of lifesaving procedures in rural hospitals and ambulatory surgery centers, and reflecting broader industry focus on flexible, point-of-care perfusion solutions.

To get more insights about this report Download Free Sample Report

Heart Lung Machine Market Driver

Increasing volume of cardiac surgeries worldwide

The rise in global cardiac surgical procedures, particularly open-heart surgeries such as coronary artery bypass grafting and valve replacements, is a major driver for market growth. As cardiovascular disease prevalence escalates across both developed and emerging regions, hospitals are investing in modern cardiopulmonary bypass systems to meet the growing procedural demand. For example, healthcare facilities reported a 37% increase in bypass machine usage tied to rising surgery volumes, directly boosting equipment procurement and upgrades.

Graph: Cardiac Surgery performed from 2019-2023 in Australia

Source: Straits Research

Market Restraints

High capital and operational costs are limiting adoption

A notable restraint in the heart-lung machine market is the high acquisition and ongoing operational costs associated with advanced cardiopulmonary bypass systems. These machines require substantial capital investment, frequently costing hundreds of thousands of dollars per unit, and involve expensive maintenance agreements, specialized disposable components, and training for clinical staff. These financial burdens hinder adoption in smaller hospitals and resource-limited healthcare facilities, slowing market growth in cost-sensitive regions.

Market Opportunities

Growth in pediatric and specialized cardiac perfusion solutions

A notable market opportunity in the heart-lung machine market stems from increasing demand for pediatric and specialty cardiopulmonary bypass systems, as manufacturers develop miniaturized and tailored solutions for neonatal and infant surgeries. For example, Terumo’s pediatric-specific CPB machines and Biocompatible low-prime circuits are gaining adoption in children’s heart centers, addressing critical surgical necessities and opening new revenue segments for device makers.

Regional Analysis

North America dominated the heart lung machine market in 2025, accounting for 41.29% market share in 2025, driven by the expanding deployment of hybrid operating rooms (ORs) that integrate advanced perfusion platforms directly with imaging and surgical systems for seamless cardiopulmonary bypass support during complex interventions. Leading U.S. and Canadian cardiac hospitals increasingly favor these ORs to enhance procedural precision, workflow efficiency, and patient safety, driving demand for compatible heart lung machines.

In Canada, the market growth is supported by its publicly funded healthcare system that ensures comprehensive access to cardiac surgical support equipment across provinces, enabling wider procurement of heart lung machines in secondary cities, as hospitals upgrade cardiovascular surgical capacity to meet population demands.

Asia Pacific Market Insights

Asia Pacific is emerging as a fastest growing region with a CAGR of 8.47% from 2026-2034. This growth is augmented by a rapid shift toward domestically manufactured, compact cardiopulmonary bypass systems tailored for regional hospital requirements in China and Southeast Asia. Local production reduces dependency on imports, lowers unit costs, and accelerates installations in emerging cardiac centers, uniquely boosting market penetration across secondary and tertiary healthcare facilities.

In Australia, the heart lung machine market is experiencing notable growth due to targeted government investment in advanced cardiac technologies, such as the AUD 50 million Artificial Heart Frontiers Program that supports research and development of next generation cardiac support systems, stimulating clinical adoption and local innovation in extracorporeal circulation equipment.

Regional Market Share (%) in 2025

Source: Straits Research

Europe Market Insights

Europe is witnessing steady growth in the heart lung machine market during 2026–2034, driven by the unified clinical guidelines from the European Society of Cardiology, which standardize cardiopulmonary bypass practices across member states. These evidence based protocols encourage adoption of advanced, interoperable heart lung machines, improving procedural consistency and driving higher procurement by regional cardiac centers.

Germany is experiencing notable growth in the heart lung machine market due to the exceptionally high concentration of tertiary level cardiac surgery centers that perform over 11,000 extracorporeal circulation dependent procedures annually, driving consistent demand for heart lung machines and specialized perfusion technologies across the country’s surgical hospital network.

Latin America Market Insights

Latin America market growth in the heart lung machine market, driven by the rapid expansion of advanced heart and lung transplant programs, which require high specification cardiopulmonary bypass systems for complex combined organ procedures. Countries like Brazil now perform thousands of transplants annually, increasing demand for dual support devices and specialized perfusion equipment. This maturing transplant infrastructure uniquely bolsters regional market growth.

Brazil's heart-lung machine market is growing steadily due to the establishment and adoption of perfusion practice standards by the Brazilian Society of Cardiovascular Surgery and the Brazilian Society of Extracorporeal Circulation, which formalize safety protocols and increase clinician confidence in cardiopulmonary bypass technologies, encouraging broader uptake of advanced heart lung machines across surgical centers.

Middle East and Africa Market Insights

The Middle East and Africa heart lung machine market is growing due to the region’s deliberate positioning of major cities like Dubai and Riyadh as advanced cardiac care hubs through cross border patient referral networks, attracting international cases and justifying investment in cardiopulmonary bypass systems at flagship tertiary hospitals, uniquely enhancing local equipment demand.

South Africa’s heart lung machine market is growing due to increasing integration of ECMO centric critical care programs into cardiothoracic surgery units, prompting hospitals to invest in dual capable perfusion systems useable for both extracorporeal membrane oxygenation and conventional bypass support. This expanded clinical utility boosts heart lung machine procurement in tertiary centers with advanced critical care requirements.

Component Insights

The oxygenators segment dominated the market with the highest revenue share of 26.16% in 2025, driven by the rising adoption of phosphorylcholine-coated hollow fiber membranes, which reduce microbubble formation and inflammatory response during prolonged cardiopulmonary bypass, improving biocompatibility and procedural safety.

The monitoring systems segment is projected to account for a 7.30% CAGR during the forecast period, owing to the increasing integration of near infrared spectroscopy (NIRS) based cerebral oxygenation monitoring, allowing real-time detection of perfusion imbalance and preventing neurological complications during cardiopulmonary bypass procedures.

By Component Market Share (%), 2025

Source: Straits Research

Application Insights

The coronary artery bypass grafting segment dominated the market with a revenue share of 30.65% in 2025, owing to increasing use of customized low-prime cardiopulmonary circuits specifically designed for CABG, which minimize hemodilution, reduce blood transfusion requirements, and improve patient outcomes during high-volume bypass procedures.

The heart transplant segment is projected to grow at a CAGR of 7.11% during 2026-2034, due to the adoption of organ preservation perfusion modules integrated with heart lung machines, which maintain donor heart viability longer during transportation, enabling more successful transplants and expanding the donor-recipient matching window.

End Use Insights

The hospitals segment dominated the market with a revenue share of 79.86% in 2025. This dominance is driven by the deployment of centralized perfusion hubs within multi-specialty hospitals, allowing shared heart lung machine resources across multiple cardiac operating rooms, optimizing utilization, reducing downtime, and improving cost-efficiency in high-volume surgical centers.

The cardiac centers segment is expected to grow at the fastest pace during the forecast period. This growth is stimulated by the adoption of modular, portable heart lung machines tailored for specialized cardiac units, enabling high-frequency procedures, rapid turnover between surgeries, and enhanced patient monitoring within focused, procedure specific cardiac care environments.

Competitive Landscape

The global heart lung machine market is consolidated, with a few major players accounting for the majority of revenue. Leading companies such as LivaNova, Getinge AB, Medtronic, and Terumo Corporation dominate the market through advanced product portfolios, strong hospital partnerships, and global distribution networks, while smaller regional manufacturers occupy niche segments, collectively shaping a competitive but concentrated industry landscape.

Inspira Technologies OXY B.H.N. Ltd: An emerging market player

Inspira Technologies OXY B.H.N. Ltd. is a specialized, emerging manufacturer in the heart lung machine market, focusing on single use disposable oxygenation kits and compatible cardiopulmonary bypass accessories, addressing cost and safety in cardiac surgery. Its innovative integration of low cost, high efficiency oxygenation components supports broader adoption in emerging markets and positions the company as a rising competitor in perfusion technology segments.

List of key players in Heart Lung Machine Market

1. LivaNova PLC
2. Getinge AB (Maquet)
3. Medtronic plc
4. Terumo Corporation
5. Braile Biomedica
6. Tianjin Medical
7. Xenios AG
8. Nipro Medical Corporation
9. MicroPort Scientific Corporation
10. ESCO MEDICAL
11. Chalice Medical Ltd.
12. Senko Medical Instrument Mfg. Co., Ltd.
13. Spectrum Medical
14. Hemovent GmbH
15. Elite Lifecare
16. Eurosets S.r.l.
17. Edwards Lifesciences Corporation
18. Baxter International Inc.
19. Asahi Kasei Corporation
20. Hill-Rom Holdings, Inc.
21. Others

To get more findings about this report Download Market Share

Strategic Initiative

• August 2025: LivaNova PLC launched the Essenz Perfusion System in China after the U.S., which improves clinical workflows and quality of patient care during cardiopulmonary bypass procedures.